These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13796421)

  • 21. Differences in the distribution of glutamic acid-oxalacetic acid transaminase- and aldolase-activity among serum protein fractions in patients with acute myocardial infarct and hepatocellular damage.
    TENYI M; VARGA L; KOVACS I; LEHOTAY L
    Med Exp Int J Exp Med; 1961; 4():335-40. PubMed ID: 13920250
    [No Abstract]   [Full Text] [Related]  

  • 22. Variations in serum glutamic oxaloacetic transaminase activity in experimental and clinical coronary insufficiency, pericarditis, and pulmonary infarction.
    NYDICK I; RUEGSEGGER P; WROBLEWSKI F; LADUE JS
    Circulation; 1957 Mar; 15(3):324-34. PubMed ID: 13404705
    [No Abstract]   [Full Text] [Related]  

  • 23. High serum transaminase activity in heart disease. Circulatory failure and hepatic necrosis.
    KILLIP T; PAYNE MA
    Circulation; 1960 May; 21():646-60. PubMed ID: 14409072
    [No Abstract]   [Full Text] [Related]  

  • 24. Lactic dehydrogenase versus glutamic oxalacetic acid transaminase as a diagnostic test for myocardial infarction.
    FREEMAN I; JACKSON DA; COLLIER CS
    Am J Med Sci; 1959 Jun; 237(6):768-70. PubMed ID: 13661165
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum glutamic-oxalacetic transaminase activity in conditions associated with myocardial infarction. II. Cerebral vascular accidents and congestive heart failure.
    LIEBERMAN J; LASKY II; DULKIN SI; LOBSTEIN OE
    Ann Intern Med; 1957 Mar; 46(3):497-505. PubMed ID: 13403533
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum glutamic-oxalacetic and glutamic-pyruvic transaminases in myocardial infarct].
    FORTIN P; PERROTIN M
    Prog Med (Paris); 1959 Sep; 87():300-4. PubMed ID: 13824065
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum glutamic oxaloacetic transaminase elevation and possible hepatotoxicity accompanying the administration of ethionamide.
    PHILLIPS S; TREVATHAN RD
    Am Rev Respir Dis; 1962 Aug; 86():268-9. PubMed ID: 14486256
    [No Abstract]   [Full Text] [Related]  

  • 28. Glutamic-oxalacetic transaminase in the diagnosis of myocardial infarction. I. Serum transaminase activity in relation to the clinical picture.
    BIORCK G; HANSON A
    Acta Med Scand; 1956 Oct; 155(4):317-24. PubMed ID: 13361845
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum transaminase; a test to aid in diagnosis of cardiac infarction.
    DEUTSCH A
    Calif Med; 1956 Sep; 85(3):163-4. PubMed ID: 13356176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the serum glutamic oxalecetic and serum glutamic pyruvic transaminases, and cardiac muscle transaminases in experimental myocardial infarction in dogs.
    MATHUR KS; SAPRU RP
    Indian J Med Res; 1963 Jan; 51():36-42. PubMed ID: 13933657
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinolytic activator, glutamic oxaloacetic transaminase and potassium in myocardial tissue at various stages of human myocardial infarction.
    FISCHER S; ALBRECHTSEN OK; BANG NU
    Thromb Diath Haemorrh; 1959 Sep; 3():554-65. PubMed ID: 13823131
    [No Abstract]   [Full Text] [Related]  

  • 32. [The prognostic significance of high SGOT titer in myocardial infarct].
    MASSON NG; VERHEUGT AP
    Ned Tijdschr Geneeskd; 1962 Apr; 106():858-61. PubMed ID: 14470955
    [No Abstract]   [Full Text] [Related]  

  • 33. Experience with serum glutamic oxaloacetic transaminase.
    BERKMAN F; BHARGAVA AN
    Can Med Assoc J; 1959 Jun; 80(11):861-5. PubMed ID: 13662936
    [No Abstract]   [Full Text] [Related]  

  • 34. Daily changes in serum glutamic oxalacetic acid transaminase, with reference to the clinical aspects.
    TOIVANEN P; HARRI J; KALLIOMAKI JL
    Cardiologia (Basel); 1963; 42():391-4. PubMed ID: 13985298
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute elevation of serum transaminase and lactic dehydrogenase during circulatory shock.
    SHUBIN H; WEIL MH
    Am J Cardiol; 1963 Mar; 11():327-31. PubMed ID: 13988750
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum glutamic oxalacetic transaminase in acute myocardial infarction.
    DEWAR HA; ROWELL NR; SMITH AJ
    Br Med J; 1958 Nov; 2(5105):1121-5. PubMed ID: 13584872
    [No Abstract]   [Full Text] [Related]  

  • 37. Simultaneous human serum glutamic oxalacetic transaminase; serum glutamic pyruvic transaminase and serum lactic dehydrogenase determinations.
    SENEVIRATNE KN; WATSON RS; PERERA SA
    Ceylon Med J; 1961 Jul; 6():7-11. PubMed ID: 13910663
    [No Abstract]   [Full Text] [Related]  

  • 38. The significance of alterations in serum glutamic oxaloacetic transaminase in experimental and clinical states.
    WROBLEWSKI F
    Trans N Y Acad Sci; 1956 Mar; 18(5):444-50. PubMed ID: 13312070
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum glutamic-oxaloacetic transaminase activity. A new modification and an anaytical assessment of current assay technics.
    AMADOR E; WACKER WE
    Clin Chem; 1962 Aug; 8():343-50. PubMed ID: 13860849
    [No Abstract]   [Full Text] [Related]  

  • 40. Colorimetric measurement of serum glutamic oxaloacetic transaminase.
    CABAUD P; LEEPER R; WROBLEWSKI F
    Am J Clin Pathol; 1956 Sep; 26(9):1101-5. PubMed ID: 13362163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.